| NEUROPHARMACOLOGY | 卷:112 |
| Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease | |
| Review | |
| Whitehead, Garry1  Regan, Philip1  Whitcomb, Daniel J.1,2  Cho, Kwangwook1,2  | |
| [1] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Fac Hlth Sci, Whitson St, Bristol BS1 3NY, Avon, England | |
| [2] Univ Bristol, Ctr Synapt Plast, Fac Hlth Sci, Whitson St, Bristol BS1 3NY, Avon, England | |
| 关键词: Calcium permeable AMPA receptor; Amyloid beta; Glucocorticoid; Synaptic plasticity; Hippocampus; | |
| DOI : 10.1016/j.neuropharm.2016.08.022 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) are the primary conduits of excitatory synaptic transmission. AMPARs are predominantly Ca2+-impermeable in the matured excitatory synapse, except under certain circumstances. Growing evidence implicates the Ca2+ permeability of AMPARs in the regulation of long-term synaptic plasticity and in the pathophysiology of several neurological disorders. Therefore, the Ca2+ conductance of AMPARs may have both physiological and pathological roles at synapses. However, our understandirig of the role of Ca2+ permeable AMPARs (CP-AMPARs) in Alzheimer's disease is limited. Here we discuss insights into the potential CP-AMPAR mediated pathophysiology of Alzheimer's disease, including: I. Ca2+-mediated aberrant regulation of synapse weakening mechanisms, and 2. neuronal network dysfunction in the brain. Consideration of CP-AMPARs as primary drivers of pathophysiology could help in understanding synaptopathologies, and highlights the potential of CP-AMPARs as therapeutic targets in Alzheimer's disease. This article is part of the Special Issue entitled 'lonotropic glutamate receptors'. (C) 2016 Elsevier Ltd. All rights reserved.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_neuropharm_2016_08_022.pdf | 769KB |
PDF